Jump to content

Thioproscaline

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by IznoRepeat (talk | contribs) at 15:00, 30 July 2020 (External links: remove template per TFD; gen fixes). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Thioproscaline
Names
IUPAC name
2-[3,5-dimethoxy-4-(propylsulfanyl)phenyl]ethanamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
  • InChI=1S/C13H21NO2S/c1-4-7-17-13-11(15-2)8-10(5-6-14)9-12(13)16-3/h8-9H,4-7,14H2,1-3H3 checkY
    Key: BQFDSMXQCJFKCH-UHFFFAOYSA-N checkY
  • InChI=1/C13H21NO2S/c1-4-7-17-13-11(15-2)8-10(5-6-14)9-12(13)16-3/h8-9H,4-7,14H2,1-3H3
    Key: BQFDSMXQCJFKCH-UHFFFAOYAY
  • COc1cc(cc(OC)c1SCCC)CCN
Properties
C13H21NO2S
Molar mass 255.376 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Thioproscaline, or 3,5-dimethoxy-4-propylthiophenethylamine, is a lesser-known psychedelic drug. It is the 4-propylthio analog of mescaline. Thioproscaline was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 20–25 mg, and the duration listed as 10–15 hours. Thioproscaline causes closed-eye visuals, slight open-eye visuals, and a body load. Very little data exists about the pharmacological properties, metabolism, and toxicity of thioproscaline.

See also